Lonza, Antharis partner to develop next-generation dual-payload ADCs for GI cancers
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Exclusive licensing agreement combines Lonza’s dual-payload ADC technology with Antharis’ antibody engineering expertise
Acquisition strengthens integrated radiology and pathology capabilities, enhancing access to advanced diagnostics and preventive healthcare
Veteran healthcare leader with extensive experience in hospital operations will drive operational excellence, patient-centric care, and sustainable growth in his new role
Our Global Capability Center (GCC) in Bengaluru drives our major software development initiatives. Complementing this, our Bengaluru facility manufactures antibodies for research and diagnostics. Through these integrated technology and biotech operations, we are proud to contribute to India’s growth story in the life sciences sector.
Organizations that embrace it thoughtfully today will help shape a healthier tomorrow, for India and beyond
By leveraging digital screening and remote consultation, the medical community is moving beyond the confines of the clinic
New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches
The test is designed to help clinicians either rule in or rule out amyloid pathology in patients showing signs of cognitive decline
75 bikers participated in the rally organised by Thalassemia and Sickle Cell Society to promote early screening and voluntary blood donation
The leading cancer hospital urges carrier screening to prevent thalassemia burden
Subscribe To Our Newsletter & Stay Updated